IE
IRD

Israel Englander’s Opus Genetics IRD Stock Holding History

Israel Englander’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.46M Sell
2,302,101
-328,331
-12% -$1.53M ﹤0.01% 2333
2026
Q1 		$12M Buy
2,630,432
+627,882
+31% +$2.17M 0.01% 1999
2025
Q4 		$4.03M Buy
+2,002,550
New +$4.07M ﹤0.01% 3252
2025
Q3 		– Sell
-127,844
Closed -$120K – 6558
2025
Q2 		$120K Buy
+127,844
New +$118K ﹤0.01% 5484
2025
Q1 		– Sell
-11,991
Closed -$14.3K – 6545
2024
Q4 		$14.3K Buy
+11,991
New +$13.8K ﹤0.01% 5753
2024
Q2 		– Sell
-36,628
Closed -$73.6K – 6664
2024
Q1 		$73.6K Sell
36,628
-49,238
-57% -$125K ﹤0.01% 5632
2023
Q4 		$258K Buy
+85,866
New +$254K ﹤0.01% 5042
2022
Q4 		– Sell
-24,463
Closed -$49K – 7153
2022
Q3 		$49K Sell
24,463
-11,119
-31% -$24K ﹤0.01% 6194
2022
Q2 		$68K Buy
+35,582
New +$80.9K ﹤0.01% 6077
2022
Q1 		– Sell
-47,431
Closed -$177K – 7604
2021
Q4 		$177K Buy
47,431
+21,004
+79% +$84.2K ﹤0.01% 5991
2021
Q3 		$136K Buy
+26,427
New +$122K ﹤0.01% 6290
2021
Q2 		– Sell
-12,692
Closed -$74K – 7221
2021
Q1 		$74K Buy
+12,692
New +$118K ﹤0.01% 5734
2017
Q2 		– Sell
-106
Closed -$26K – 3937
2017
Q1 		$26K Buy
+106
New +$13.7K ﹤0.01% 3421
2016
Q2 		– Sell
-53
Closed -$8K – 3659
2016
Q1 		$8K Buy
+53
New +$8.82K ﹤0.01% 3204
2014
Q2 		– Sell
-4,412
Closed -$2.29M – 3974
2014
Q1 		$2.29M Buy
+4,412
New +$2.39M 0.01% 1679

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Israel Englander's IRD Position: Q2 2026 in Review

Israel Englander reduced its Opus Genetics (IRD) stake by 12% in Q2 2026, selling an estimated $1.53M and leaving 2,302,101 shares worth $9.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Israel Englander first reported a position in IRD in Q1 2014 and has held it in 15 quarters since. The position peaked at $12M in Q1 2026. 102 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Israel Englander held 2,302,101 shares of Opus Genetics worth $9.46M as of Q2 2026.
  • Israel Englander sold 328,331 Opus Genetics shares in Q2 2026, an estimated $1.53M.
  • Opus Genetics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2333 holding.
  • Israel Englander first reported a position in Opus Genetics in Q1 2014 and has held it in 15 quarters since.
  • Israel Englander's Opus Genetics position peaked at $12M in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.